SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024150
Filing Date
2022-11-10
Accepted
2022-11-10 07:11:15
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20220930.htm   iXBRL 10-Q 3621713
2 EX-31.1 aura-ex31_1.htm EX-31.1 24890
3 EX-31.2 aura-ex31_2.htm EX-31.2 24846
4 EX-32.1 aura-ex32_1.htm EX-32.1 23283
  Complete submission text file 0000950170-22-024150.txt   10562242

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aura-20220930_cal.xml EX-101.CAL 47595
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aura-20220930_def.xml EX-101.DEF 256993
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20220930.xsd EX-101.SCH 66645
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20220930_pre.xml EX-101.PRE 369035
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20220930_lab.xml EX-101.LAB 505394
66 EXTRACTED XBRL INSTANCE DOCUMENT aura-20220930_htm.xml XML 1754995
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 221374906
SIC: 2836 Biological Products, (No Diagnostic Substances)